Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_assertion type Assertion NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_head.
- NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_assertion description "[So far expression studies of apoptosis-regulating genes on acute myeloid leukemia (AML) have mainly focused on Bcl-2 itself and most of them have not included other factors involved in drug resistance or apoptosis as parameters determining response to chemotherapy, disease progression and survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_provenance.
- NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_assertion evidence source_evidence_literature NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_provenance.
- NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_assertion SIO_000772 11410409 NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_provenance.
- NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_assertion wasDerivedFrom befree-2016 NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_provenance.
- NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_assertion wasGeneratedBy ECO_0000203 NP321190.RACvOPwRVQoCfEaaE1FxHqmDmUJDXeJoaaK4-yOnO5t2s130_provenance.